Genital Neoplasms, Female  >>  Estybon (rigosertib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Estybon (rigosertib) / Traws Pharma, SymBio Pharma, Knight Therap
NCT00856791: Effect of 2-h Infusion of ON 01910.Na in Ovarian Cancer Patients

Completed
2
1
US
ON 01910.Na, rigosertib, rigosertib sodium
Onconova Therapeutics, Inc.
Ovarian Cancer
07/11
07/11

Download Options